Nanoscope's lead product is an optogenetic gene therapy, vMCO-010, that delivers light-sensitive Multi-Characteristic Opsin (MCO) into retinal cells to ...
https://www.google.com/url?rct=j&sa=t&url=https://www.prnewswire.com/news-releases/nanoscope-president-to-deliver-talk-on-gene-therapy-for-retinal-diseases-at-association-for-ocular-pharmacology-and-therapeutics-conference-301239317.html&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNHTAWT0k-kbQ8MAUchQNqJJwnVMFQ
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.